candesartan cilexetil and paclitaxel

candesartan cilexetil has been researched along with paclitaxel in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Hira, D; Ikeda, Y; Katsube, Y; Koide, H; Minegaki, T; Morita, SY; Nishiguchi, K; Terada, T; Tsujimoto, M	1

Other Studies

2 other study(ies) available for candesartan cilexetil and paclitaxel

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Concomitant administration of candesartan cilexetil in patients on paclitaxel and carboplatin combination therapy increases risk of severe neutropenia . International journal of clinical pharmacology and therapeutics, 2018, Volume: 56, Issue:7 Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Carboplatin; Drug Interactions; Female; Humans; Hypertension; Incidence; Japan; Male; Middle Aged; Neutropenia; Paclitaxel; Retrospective Studies; Risk Factors; Severity of Illness Index; Tetrazoles; Time Factors; Treatment Outcome	2018

Article

Year

Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.

Chemical research in toxicology, 2010, Volume: 23, Issue:1

Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010

Concomitant administration of candesartan cilexetil in patients on paclitaxel and carboplatin combination therapy increases risk of severe neutropenia .

International journal of clinical pharmacology and therapeutics, 2018, Volume: 56, Issue:7

Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Carboplatin; Drug Interactions; Female; Humans; Hypertension; Incidence; Japan; Male; Middle Aged; Neutropenia; Paclitaxel; Retrospective Studies; Risk Factors; Severity of Illness Index; Tetrazoles; Time Factors; Treatment Outcome

2018